Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gamma tocopherol in allergic asthma (O3 response)
NCT02911688Phase 2Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Sep 2016
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in allergic asthma comparing Gamma Tocopherol Arm with Placebo Arm (2 arms). Primary endpoint: Sputum Percent Neutrophils. Started Sep 2016; status: completed.
02
Drugs
gamma-tocopherol
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT02911688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02911688.